|Product name||SARS-COV-2 Neutralizing Antibody|
|Description||SARS-COV-2 Neutralizing Antibody is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293). This antibody recognizes the SARS-CoV-2 Spike Protein RBD domain and inhibits the interaction between SARS-CoV-2 RBD and ACE2 with an IC50 of 0.496 μg/mL using SARS-CoV-2 Inhibitor Screening Kit(Cat.No.RK04149).|
|Affinity purification by||Protein A|
|Purity||>95% by SDS-PAGE.|
|Endotoxin||< 0.1 EU/μg of the protein by LAL method.|
|Formulation||Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.2, with 10% Trehalose.|
|Storage||Store the lyophilized protein at -20°C to -80 °C for long term.|
Avoid repeated freeze/thaw cycles.
* For research use only. Not for therapeutic or diagnostic purposes.
Submit your question about A19215 below and we will get back to you within one business day.
Alternatively, call us at 888.754.5670.